The Journal of Biochemistry · 2010 · 76 citations · 26 references
Life SciencesMolecular BiologyPharmacologyCell SignalingMolecular PharmacologySignal TransductionProtein Kinase CascadesProtein PhosphorylationReceptor RegulationReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsActivationActivation Loop RegulationKinase Activation MechanismsPhosphorylation RegulationProtein Tyrosine PhosphorylationReceptor AutophosphorylationReceptor Tyrosine Kinase ActivationResistance To Tyrosine Kinase Inhibitors
The activation of receptor tyrosine kinases (RTKs) is tightly regulated through a variety of mechanisms. Kinetic studies show that activation of c-Kit RTK occurs through an inter-molecular autophosphorylation. Phosphopeptide mapping of c-Kit reveals that 14-22 phosphates are added to each mol of wild-type (WT) c-Kit during the activation. Phosphorylation sites are found on the JM, kinase insert (KID), c-terminal domains and the activation loop (A-loop), but only the sites on the JM domain contribute to the kinase activation. The A-loop tyrosine (Y(823)) is not phosphorylated until very late in the activation (>90% completion), indicating that the A-loop phosphorylation is not required for c-Kit activation. A sunitinib-resistant mutant D816H that accelerates auto-activation by 184-fold shows no phosphorylation on the A-loop tyrosine after full activation. A loss-of-phosphorylation mutation Y823F remains fully competent in auto-activation. Similar to WT and D816H, the unactivated Y823F mutant binds sunitinib and imatinib with high affinity (K(D) = 5.9 nM). But unlike the WT and D816H where the activated enzymes lose the ability to bind the two drugs, activated Y823F binds the two inhibitors effectively. These observations suggest that the A-loop of activated Y823F remains flexible and can readily adopt unactivated conformations to accommodate DFG-out binders.
26
K.S. Gajiwala, Joe C. Wu, James G. Christensen et al. · Proceedings of the National Academy of Sciences · 2009 · 386 citations · Full text
Medicine, Oncology, Pharmacology +16